SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,644,586 | -19.8% | 511,821 | +14.8% | 0.00% | -100.0% |
Q2 2023 | $4,541,825 | +192.1% | 445,714 | +160.0% | 0.00% | – |
Q1 2023 | $1,554,997 | +223963.0% | 171,444 | +76.9% | 0.00% | – |
Q4 2022 | $694 | -99.9% | 96,921 | +13.8% | 0.00% | – |
Q3 2022 | $555,000 | +46.8% | 85,185 | +8.4% | 0.00% | – |
Q2 2022 | $378,000 | -3.8% | 78,574 | +13.5% | 0.00% | – |
Q1 2022 | $393,000 | +10.1% | 69,252 | -2.7% | 0.00% | – |
Q4 2021 | $357,000 | -24.5% | 71,209 | -0.0% | 0.00% | – |
Q3 2021 | $473,000 | +16.5% | 71,223 | +7.1% | 0.00% | – |
Q2 2021 | $406,000 | -37.7% | 66,475 | -32.2% | 0.00% | – |
Q1 2021 | $652,000 | +34.7% | 98,080 | +7.2% | 0.00% | – |
Q4 2020 | $484,000 | -23.8% | 91,520 | +7.4% | 0.00% | – |
Q3 2020 | $635,000 | +14.8% | 85,247 | +13.3% | 0.00% | – |
Q2 2020 | $553,000 | +141.5% | 75,252 | +142.5% | 0.00% | – |
Q1 2020 | $229,000 | -34.6% | 31,028 | -50.0% | 0.00% | – |
Q4 2019 | $350,000 | +81.3% | 62,056 | +89.9% | 0.00% | – |
Q3 2019 | $193,000 | +85.6% | 32,683 | 0.0% | 0.00% | – |
Q2 2019 | $104,000 | -37.0% | 32,683 | -40.6% | 0.00% | – |
Q1 2019 | $165,000 | -57.7% | 55,043 | -47.0% | 0.00% | – |
Q4 2018 | $390,000 | +32.2% | 103,840 | +106.5% | 0.00% | – |
Q3 2018 | $295,000 | +11.7% | 50,285 | +7.4% | 0.00% | – |
Q2 2018 | $264,000 | -47.3% | 46,801 | +15.7% | 0.00% | – |
Q1 2018 | $501,000 | – | 40,448 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |